Kronos Bio Operating Expenses 2011-2026 | KRON

Annual Operating Expenses Kronos Bio

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
128 M	137 M	151 M	58 M	16.8 M	6.64 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
151 M	6.64 M	83 M

Quarterly Operating Expenses Kronos Bio

2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
11.3 M	-	18.1 M	20.7 M	34.5 M	-	34.7 M	34 M	29.7 M	-	33.5 M	33.5 M	36.4 M	-	33.7 M	29.1 M	26.2 M	-	20.8 M	8.8 M	7.35 M	-	4.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36.4 M	4.32 M	24.5 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	292 M	$ 3.54	-0.56 %	$ 1.06 B	Canada
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
AC Immune SA ACIU	79.7 M	$ 3.2	2.24 %	$ 229 M	Schweiz
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
ADC Therapeutics SA ADCT	334 M	$ 4.17	-1.18 %	$ 105 M	Schweiz
Aptorum Group Limited APM	20.7 M	$ 0.8	1.81 %	$ 4.36 M	China
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Arcturus Therapeutics Holdings ARCT	158 M	$ 6.55	-1.21 %	$ 179 M	Israel
argenx SE ARGX	2.27 B	$ 710.47	1.02 %	$ 25 B	Niderland
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.41	-5.54 %	$ 8.2 B	Australia
Ascendis Pharma A/S ASND	338 M	$ 229.89	-0.49 %	$ 5 B	Danmark
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
BioCardia BCDA	15.7 M	$ 1.28	0.55 %	$ 27.1 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Atea Pharmaceuticals AVIR	181 M	$ 6.12	1.16 %	$ 499 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 3.51	-2.23 %	$ 7.64 B	Israel
Catalyst Biosciences CBIO	105 M	$ 11.32	-2.25 %	$ 1.01 B	USA
Anika Therapeutics ANIK	51.6 M	$ 14.64	1.92 %	$ 215 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
AVEO Pharmaceuticals AVEO	44.9 M	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
CNS Pharmaceuticals CNSP	14.9 M	$ 2.28	-6.94 %	$ 872 K	USA
Aytu BioScience AYTU	53.7 M	$ 2.64	-	$ 16.6 M	USA
Curis CRIS	33.9 M	$ 0.88	2.58 %	$ 5.55 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.51	-	$ 385 M	Britain
BioNTech SE BNTX	512 M	$ 92.24	1.88 %	$ 27.2 B	Germany
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany